Skip to main content

Integral Health Asset Management, LLC

Source: SEC Form 13F · as of Mar 2026

Integral Health Asset Management, LLC holds 40 biotech & pharma companies tracked by BioSniper, totaling $980.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

40

Total value held

$980.7M

BioSniper AIPage evidence connected

Prepared research question

What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INSMINSMED Inc1,500,000$245.3M
RVMDREVOLUTION MEDICINES, INC.1,500,000$145.9M
CYTKCYTOKINETICS INC1,600,000$105.5M
REGNREGENERON PHARMACEUTICALS, INC.85,000$65.7M
ROIVRoivant Sciences Ltd.2,000,000$55.4M
RYTMRHYTHM PHARMACEUTICALS, INC.600,000$52.2M
SRRKScholar Rock Holding Corp500,000$24.6M
BBIOBridgeBio Pharma, Inc.275,000$20.4M
ARWRARROWHEAD PHARMACEUTICALS, INC.300,000$18.8M
ORICOric Pharmaceuticals, Inc.1,400,000$17.7M
ALMSALUMIS INC.800,000$17.6M
QUREuniQure N.V.900,000$14.7M
GILDGILEAD SCIENCES, INC.100,000$13.9M
COGTCogent Biosciences, Inc.350,000$13.5M
DNTHDianthus Therapeutics, Inc. /DE/150,000$12.6M
RGNXREGENXBIO Inc.1,500,000$12.6M
SLNOSOLENO THERAPEUTICS INC325,000$10.9M
IRONDisc Medicine, Inc.170,000$10.9M
NRIXNurix Therapeutics, Inc.700,000$10.8M
TNGXTango Therapeutics, Inc.450,000$9.4M
IONSIONIS PHARMACEUTICALS INC125,000$9.4M
SANASana Biotechnology, Inc.3,200,000$9.2M
BHVNBiohaven Ltd.1,000,000$8.5M
VKTXViking Therapeutics, Inc.250,000$8.1M
DFTXDefinium Therapeutics Inc.400,000$7.6M
BEAMBeam Therapeutics Inc.300,000$7.1M
RZLTRezolute, Inc.2,000,000$6.1M
CAPRCAPRICOR THERAPEUTICS, INC.200,000$6.1M
AXSMAxsome Therapeutics, Inc.35,000$5.9M
PTGXProtagonist Therapeutics, Inc50,000$5.3M
FBRXForte Biosciences, Inc.150,000$3.9M
LBRXLB PHARMACEUTICALS INC150,000$3.7M
SVRASavara Inc600,000$3.3M
RLMDRELMADA THERAPEUTICS, INC.450,000$3.1M
IMCRImmunocore Holdings plc100,000$3.0M
MAZEMaze Therapeutics, Inc.100,000$3.0M
TENXTENAX THERAPEUTICS, INC.167,000$2.7M
OLMAOlema Pharmaceuticals, Inc.150,000$2.2M
IVAInventiva S.A.400,000$2.2M
SIONSionna Therapeutics, Inc.50,000$2.0M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.